Clinical Trial Update: New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for new onset type 1 diabetes evaluating mycophenolate mofetil-daclizumab; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mycophenolate mofetil-daclizumab

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2016-08-16